Suicide PreventionNCT07071922
User Evaluation of Zelfmoord1813.be and Its Related Websites
An observational study of Suicide Prevention and User Experience, run by University Ghent at 1 site in Belgium.
Trial summary
Monitoring the availability and accessibility of suicide prevention information in Flanders remains crucial. In 2022, 1,024 people died by suicide in Flanders, and approximately 10,000 individuals required emergency care following a suicide attempt. Read more about this study
- Who is it for?
- Ages 16 years and olderHealthy volunteers can take part
- Conditions the study is for
- Suicide Prevention, User Experience
- How many people
- 3,000 participants
- Where
- 1 siteBelgium
- Study dates
- 3 Jul 2025to 31 Mar 2026
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 16 years and older
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Study population: Users of Zelfmoord1813.be and its related websites
Who may be able to join
- 16 y/o or older
- visit(ed) websites zelfmoord1813.be, mee-leven.be, werkgroepverder.be or komuitjekop.be
Who cannot join
- /
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Belgium1 site, 1 recruiting
- Recruiting
Flemish Centre of Expertise in Suicide Prevention
Ghent, 9000
Eva De Jaegere, PhD, +32(0)9 332 07 75, eva.dejaegere@ugent.be
About this study
Monitoring the availability and accessibility of suicide prevention information in Flanders remains crucial. In 2022, 1,024 people died by suicide in Flanders, and approximately 10,000 individuals required emergency care following a suicide attempt.
The third Flemish Suicide Prevention Action Plan outlines several strategies aimed at achieving the health objective of reducing the suicide rate by 10% by 2030 compared to 2020.
Read more
One of the initiatives under the first Flemish Suicide Prevention action plan was the creation of a central online platform for suicide prevention. This led to the launch of Zelfmoord1813.be at the end of 2013. The platform serves as a central point of access to relevant and scientifically grounded information on suicide prevention in Flanders. It provides immediate crisis support through Zelfmoordlijn 1813, a free and anonymous helpline available via phone, chat, or email. In addition, the site offers resources for professionals, journalists, students, and others seeking information on suicide prevention.
Zelfmoord1813.be targets a broad audience across all age groups . The website is managed by the Flemish Centre of Expertise in Suicide Prevention, the government-appointed partner organization for suicide prevention in Flanders. One of the key responsibilities of the Flemish Centre of Expertise in Suicide Prevention is to regularly assess the use, reach, and relevance of Zelfmoord1813.be, partly through recurring user research.
This user research investigates visitors' reasons for accessing the platform, whether they find what they are looking for, and their satisfaction with the content. The findings help evaluate whether all target groups are being reached effectively and inform future strategies for promotion, content development, and improvements.
A first user study was conducted in 2020. The researchers now aim to repeat this evaluation. In recent years, three affiliated websites have also been launched: WerkgroepVerder.be (for suicide bereavement support), Mee-Leven.be (focused on suicide prevention in the social environment) and KomUitJeKop.be (specifically tailored to men). These websites are also managed by the Flemish Centre of Expertise in Suicide Prevention and will be included in the current study.
The study aims to include 3,000 participants aged 16 and older. Visitors to Zelfmoord1813.be, WerkgroepVerder.be, Mee-Leven.be or KomUitJeKop.be will see a pop-up invitation to participate after 30 seconds, which disappears after 20 seconds. If they click "yes," they are redirected to a Qualtrics page, where they complete a short informed consent and a 5-minute questionnaire before being returned to the original website.
Additionally, a message on each website will read: "We are curious about your opinion of our website. Please take your time to explore the site. When you're ready, you can share your feedback by clicking this link." This allows users to participate after reviewing the content at their own pace.
- Conditions
- Suicide Prevention, User Experience
- Being tested
- No intervention
- Medical subject headings
- Suicide Prevention
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
No interventionOther
Observational one-time questionnaire study without intervention
| Study group | Role | What they receive |
|---|---|---|
| Users of Zelfmoord1813 and related websites | individuals of 16y/o or older who visit(ed) the websites zelfmoord1813.be, werkgroepverder.be, mee-leven.be or komuitjekop.be and understand Dutch Receives: Other: No intervention |
What is being measured
The primary outcome is the main question the study is designed to answer.
Evaluation of the websites
self-developed questionnaire consisting of 1 multiple-choice question about how they found the website; 1 multiple-choice question on their reason for visiting the website, 1 multiple-choice question on how often they visited the website before; 1 question to rate the website on a scale of 1-10; 2 questions with statements about the website and its content to be rated on 5 point Likert scale; 1 multiple-choice question on the use of AI on websites and 3 open questions for feedback (what was good, what was less good and other suggestions)
Measured: Baseline. Completing the questionnaire will take about 5 minutes
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 Jul 2025
- Study start3 Jul 2025
- Primary completion31 Mar 2026 (estimated)
- Study completion31 Mar 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Suicide PreventionStudies of the same condition, open and under way.
- More trials run by University GhentThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Cross-sectional
- Enrolment
- 3,000 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University Ghent
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Gwendolyn Portzky, PhD, Principal investigator, University Ghent
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07071922
- Sponsor's protocol ID
- ONZ-2025-0058
- Status last verified
- Jul 2025
- First submitted
- 8 Jul 2025
- Last updated
- 17 Jul 2025
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 17 Jul 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- User Evaluation of Zelfmoord1813.be and Its Related Websites
- ClinicalTrials.gov ID
- NCT07071922
- Acronym / sponsor ID
- ONZ-2025-0058
- Conditions
- Suicide Prevention, User Experience
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 3,000 participants (estimated)
- Lead sponsor
- University GhentUniversity, hospital or other
- Study start
- 3 Jul 2025 (actual)
- Primary completion
- 31 Mar 2026 (estimated)
- Study completion
- 31 Mar 2026 (estimated)
- First posted
- 17 Jul 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Monitoring the availability and accessibility of suicide prevention information in Flanders remains crucial. In 2022, 1,024 people died by suicide in Flanders, and approximately 10,000 individuals required emergency care following a suicide attempt.
The third Flemish Suicide Prevention Action Plan outlines several strategies aimed at achieving the health objective of reducing the suicide rate by 10% by 2030 compared to 2020.
One of the initiatives under the first Flemish Suicide Prevention action plan was the creation of a central online platform for suicide prevention. This led to the launch of Zelfmoord1813.be at the end of 2013. The platform serves as a central point of access to relevant and scientifically grounded information on suicide prevention in Flanders. It provides immediate crisis support through Zelfmoordlijn 1813, a free and anonymous helpline available via phone, chat, or email. In addition, the site offers resources for professionals, journalists, students, and others seeking information on suicide prevention.
Zelfmoord1813.be targets a broad audience across all age groups . The website is managed by the Flemish Centre of Expertise in Suicide Prevention, the government-appointed partner organization for suicide prevention in Flanders. One of the key responsibilities of the Flemish Centre of Expertise in Suicide Prevention is to regularly assess the use, reach, and relevance of Zelfmoord1813.be, partly through recurring user research.
This user research investigates visitors' reasons for accessing the platform, whether they find what they are looking for, and their satisfaction with the content. The findings help evaluate whether all target groups are being reached effectively and inform future strategies for promotion, content development, and improvements.
A first user study was conducted in 2020. The researchers now aim to repeat this evaluation. In recent years, three affiliated websites have also been launched: WerkgroepVerder.be (for suicide bereavement support), Mee-Leven.be (focused on suicide prevention in the social environment) and KomUitJeKop.be (specifically tailored to men). These websites are also managed by the Flemish Centre of Expertise in Suicide Prevention and will be included in the current study.
The study aims to include 3,000 participants aged 16 and older. Visitors to Zelfmoord1813.be, WerkgroepVerder.be, Mee-Leven.be or KomUitJeKop.be will see a pop-up invitation to participate after 30 seconds, which disappears after 20 seconds. If they click "yes," they are redirected to a Qualtrics page, where they complete a short informed consent and a 5-minute questionnaire before being returned to the original website.
Additionally, a message on each website will read: "We are curious about your opinion of our website. Please take your time to explore the site. When you're ready, you can share your feedback by clicking this link." This allows users to participate after reviewing the content at their own pace.
Study design
- Observational model
- Case only
- Time perspective
- Cross-sectional
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Users of Zelfmoord1813 and related websites | – | Other: No interventionindividuals of 16y/o or older who visit(ed) the websites zelfmoord1813.be, werkgroepverder.be, mee-leven.be or komuitjekop.be and understand Dutch |
Who may qualify
- Ages
- 16 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Users of Zelfmoord1813.be and its related websites
Key inclusion criteria (2 listed)
- 16 y/o or older
- visit(ed) websites zelfmoord1813.be, mee-leven.be, werkgroepverder.be or komuitjekop.be
Key exclusion criteria (1 listed)
- /
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| No interventionObservational one-time questionnaire study without intervention | Other | Users of Zelfmoord1813 and related websites |
Primary outcome
Evaluation of the websites
Time frame: Baseline. Completing the questionnaire will take about 5 minutes
self-developed questionnaire consisting of 1 multiple-choice question about how they found the website; 1 multiple-choice question on their reason for visiting the website, 1 multiple-choice question on how often they visited the website before; 1 question to rate the website on a scale of 1-10; 2 questions with statements about the website and its content to be rated on 5 point Likert scale; 1 multiple-choice question on the use of AI on websites and 3 open questions for feedback (what was good, what was less good and other suggestions)
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 17 Jul 2025.
- Individual participant dataSharing planned: No
Related trials for Suicide Prevention
Recruiting
Preventing Suicidal Behavior With Diverse High-Risk Youth in Acute Care Settings
Suicide, Attempted, Suicide Ideation
Recruiting
Exploring The Effect of TikTok Trigger Warnings in a Clinical Sample of Youth at Risk of Suicide
Suicide Prevention, Social Media Users
Not yet recruitingPhase 1/2
Reducing Firearm Suicide Among Veterans: Evaluating the Effectiveness of Peer-Delivered Lethal Means Counseling
Suicide, Secure Firearm Storage
Recruiting
Developing a Recovery-Oriented Suicide Prevention Program for Young People at Clinical High Risk for Psychosis
Clinical High Risk for Psychosis (CHR), Suicidal Ideation
Not yet recruitingPhase 2
Intravenous Ketamine for Acute Suicidal Crisis and Psychiatric Hospital Length of Stay
Suicidal Ideation, Suicidal Behavior
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Gwendolyn Portzky, PhD principal investigator
University Ghent
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Suicide Prevention and User Experience, run by University Ghent at 1 site in Belgium.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 17 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Eva De Jaegere, PhD (+32 (0)9 332.07.75, eva.dejaegere@ugent.be), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Evaluation of the websites (time frame: Baseline. Completing the questionnaire will take about 5 minutes). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Jul 2025.